The recent FDA Fast Track designation for BioRestorative Therapies' BRTX-100 program marks a significant milestone in the treatment of chronic lumbar disc disease (cLDD). Given the debilitating nature of cLDD and its prevalence among middle-aged Americans, this development has sparked
A groundbreaking advancement in medical imaging technology developed by researchers at the University of Houston promises to significantly transform medical diagnostics. This innovative development centers around a sophisticated 3D imaging system that offers enhanced precision and efficiency
Ivan Kairatov is a biopharma expert with extensive knowledge of technology and innovation in the industry. He has significant experience in research and development and is here to discuss recent findings about lung abnormalities in children and adolescents with long COVID. What is long COVID, and
The transformative impact of AI-based algorithms on the health care industry offers both immense potential for improving medical outcomes and significant challenges related to bias and disparities. The unexpected discovery by radiologist Judy Gichoya, M.D., and her team that AI could predict a
Appendiceal cancer, a rare malignancy, presents significant challenges due to the lack of standardized screening guidelines, identifiable risk factors, and a common tumor classification system. These hurdles often result in delayed diagnoses and poor prognoses for patients. The estimated annual
In today’s healthcare landscape, data is more abundant than ever. Hospitals, research institutions, and medical professionals collect vast amounts of information—from patient histories and lab results to imaging scans and clinical trial data. However, the sheer volume and complexity of this data mak
Recent advancements in healthcare are uncovering surprising new uses for existing medications, and one prominent example is Ozempic (semaglutide). Originally hailed for its effectiveness in treating diabetes and aiding in weight loss, Ozempic is now being investigated for its potential to address
Duchenne muscular dystrophy (DMD) is a devastating genetic disorder that progressively deteriorates muscle function, posing a major challenge for patients and their families. Recently, a promising breakthrough has emerged in the form of Solid Biosciences' experimental gene therapy, SGT-003,
The lab automation market is undergoing a significant transformation, driven by technological advancements, increasing precision demands, and the need for efficiency in laboratory operations. Lab automation involves using automated equipment and systems to execute laboratory tasks such as sample
The recent FDA Fast Track designation for BR55, developed by Bracco Imaging, marks a significant milestone in the diagnostic imaging industry. This novel molecular imaging ultrasound contrast agent specifically targets vascular endothelial growth factor receptor 2 (VEGFR2), a receptor highly
